KalVista Pharmaceuticals, Inc.·4

Oct 1, 4:58 PM ET

Unkart Edward W 4

4 · KalVista Pharmaceuticals, Inc. · Filed Oct 1, 2021

Insider Transaction Report

Form 4
Period: 2021-09-30
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2021-09-30+10,00010,000 total
    Exercise: $17.45Exp: 2031-09-29Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option vests over a 12 month period: 1/12th on October 30, 2021, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION